Literature DB >> 20735984

MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts.

Liang Zheng1, Chan-Chan Xu, Wen-Dong Chen, Wei-Li Shen, Cheng-Chao Ruan, Li-Min Zhu, Ding-Liang Zhu, Ping-Jin Gao.   

Abstract

MicroRNAs (miRNAs), which are genomically encoded small RNAs, negatively regulate target gene expression at the post-transcriptional level. Our recent study indicated that microRNA-155 (miR-155) might be negatively correlated with blood pressure, and it has been suggested that miR-155-mediated target genes could be involved in the cardiovascular diseases. Bioinformatic analyses predict that angiotensin II type 1 receptor (AT(1)R) is a miR-155 target gene. The present study investigated the potential role of miR-155 in regulating AT(1)R expression and phenotypic differentiation in rat aortic adventitial fibroblasts (AFs). Luciferase assay demonstrated that miR-155 suppressed AT(1)R 3'-UTR reporter construct activity. miR-155 overexpression in AFs did not reduce target mRNA levels, but significantly reduced target protein expression. In addition, AFs transfected with pSUPER/miR-155 exhibited reduced Ang II-induced ERK1/2 activation. miR-155 overexpression in cells attenuated Ang II-induced α-smooth muscle actin (α-SMA, produces myofibroblast) expression, but did not transform growth factor beta-1 (TGF-β1). This study demonstrated that miR-155 could have an important role in regulating adventitial fibroblast differentiation and contribute to suppression of AT(1)R expression.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20735984     DOI: 10.1016/j.bbrc.2010.08.067

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

Review 1.  Non-coding RNAs: key regulators of smooth muscle cell fate in vascular disease.

Authors:  Nicholas J Leeper; Lars Maegdefessel
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

Review 2.  Noncoding RNAs in smooth muscle cell homeostasis: implications in phenotypic switch and vascular disorders.

Authors:  N Coll-Bonfill; B de la Cruz-Thea; M V Pisano; M M Musri
Journal:  Pflugers Arch       Date:  2016-04-25       Impact factor: 3.657

Review 3.  Noncoding RNAs in the Regulatory Network of Hypertension.

Authors:  Gengze Wu; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

4.  Angiotensin receptor type 1 single nucleotide polymorphism 1166A/C is associated with malignant arrhythmias and altered circulating miR-155 levels in patients with chronic heart failure.

Authors:  Raul R Blanco; Harland Austin; Richard N Vest; Ravinder Valadri; Wei Li; Bernard Lassegue; Qing Song; Barry London; Samuel C Dudley; Heather L Bloom; Charles D Searles; A Maziar Zafari
Journal:  J Card Fail       Date:  2012-08-09       Impact factor: 5.712

5.  Angiotensin II type 1 receptor gene polymorphism and serum angiotensin-converting enzyme level in Egyptian children with systemic lupus erythematosus.

Authors:  Rasha Mohamed Saleh Shoaib; Ayman Hammad; Sohier Yahia; Afaf Elsaid; Camelia Adly Abdel-Malak
Journal:  Clin Rheumatol       Date:  2018-08-09       Impact factor: 2.980

6.  miR-155 functions downstream of angiotensin II receptor subtype 1 and calcineurin to regulate cardiac hypertrophy.

Authors:  Yong Yang; Yong Zhou; Zheng Cao; Xin Zhu Tong; Hua Qiang Xie; Tao Luo; Xian Ping Hua; Han Qin Wang
Journal:  Exp Ther Med       Date:  2016-07-05       Impact factor: 2.447

7.  Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics.

Authors:  Mohammad Iqbal Rather; Mathighatta N Nagashri; Shivananda S Swamy; Kodaganur S Gopinath; Arun Kumar
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

8.  Secreted Monocyte miR-27a, via Mesenteric Arterial Mas Receptor-eNOS Pathway, Causes Hypertension.

Authors:  Xue Zou; Jialiang Wang; Caiyu Chen; Xiaorong Tan; Yu Huang; Pedro A Jose; Jian Yang; Chunyu Zeng
Journal:  Am J Hypertens       Date:  2020-01-01       Impact factor: 2.689

Review 9.  Endothelial microRNAs and atherosclerosis.

Authors:  Xinghui Sun; Nathan Belkin; Mark W Feinberg
Journal:  Curr Atheroscler Rep       Date:  2013-12       Impact factor: 5.113

10.  MicroRNA-155 deletion promotes tumorigenesis in the azoxymethane-dextran sulfate sodium model of colon cancer.

Authors:  Kandy T Velázquez; Reilly T Enos; Jamie L McClellan; Taryn L Cranford; Ioulia Chatzistamou; Udai P Singh; Mitzi Nagarkatti; Prakash S Nagarkatti; Daping Fan; E Angela Murphy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-07       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.